Evidence map›Paper›PMID 25050824›Full record

ArticlePloS one2014

Specific deletion of LDL receptor-related protein on macrophages has skewed in vivo effects on cytokine production by invariant natural killer T cells.

Roman Covarrubias, Ashley J Wilhelm, Amy S Major

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The iNKT Cell-Macrophage Axis in Homeostasis and Disease.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Natural killer T cells in atherosclerosis.Nature reviews. Cardiology · 2017
    Review
  7. Article
  8. The Expression of LDL-R in CD8In vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Roman CovarrubiasDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Ashley J WilhelmDepartment of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Amy S MajorDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America; Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Vanderbilt University Medical Center · US

Funding

TRAINING GRANT IN MECHANISMS OF VASCULAR DISEASET32HL007751 · NHLBI · VANDERBILT UNIVERSITY · PI BOCK, PAUL E · 1994 to 2014
$6.6M
Role of iNKT Cells in Autoimmunity and AtherosclerosisR01HL089310 · NHLBI · VANDERBILT UNIVERSITY · PI MAJOR, AMY S · 2007 to 2011
$2.2M
The Role of Regulatory B Cells in Lupus and AtherosclerosisF32HL114244 · NHLBI · VANDERBILT UNIVERSITY · PI WILHELM, ASHLEY J · 2013 to 2015
$146k
The Role of LRP in the Activation of Invariant Natural Killer T CellsF31AI102544 · NIAID · VANDERBILT UNIVERSITY · PI COVARRUBIAS, ROMAN · 2013 to 2014
$55k
NHLBI NIH HHS 1F32HL114244-01A1NHLBI NIH HHS 5T32HL007751NHLBI NIH HHS F32 HL114244NHLBI NIH HHS R01HL989310NHLBI NIH HHS T32 HL007751NIAID NIH HHS 1F31AI102544-01A1NIAID NIH HHS F31 AI102544
6 · The paper itself

Abstract

Expression of molecules involved in lipid homeostasis such as the low density lipoprotein receptor (LDLr) on antigen presenting cells (APCs) has been shown to enhance invariant natural killer T (iNKT) cell function. However, the contribution to iNKT cell activation by other lipoprotein receptors with shared structural and ligand binding properties to the LDLr has not been described. In this study, we investigated whether a structurally related receptor to the LDLr, known as LDL receptor-related protein (LRP), plays a role in iNKT cell activation. We found that, unlike the LDLr which is highly expressed on all immune cells, the LRP was preferentially expressed at high levels on F4/80+ macrophages (MΦ). We also show that CD169+ MΦs, known to present antigen to iNKT cells, exhibited increased expression of LRP compared to CD169- MΦs. To test the contribution of MΦ LRP to iNKT cell activation we used a mouse model of MΦ LRP conditional knockout (LRP-cKO). LRP-cKO MΦs pulsed with glycolipid alpha-galactosylceramide (αGC) elicited normal IL-2 secretion by iNKT hybridoma and in vivo challenge of LRP-cKO mice led to normal IFN-γ, but blunted IL-4 response in both serum and intracellular expression by iNKT cells. Flow cytometric analyses show similar levels of MHC class-I like molecule CD1d on LRP-cKO MΦs and normal glycolipid uptake. Survey of the iNKT cell compartment in LRP-cKO mice revealed intact numbers and percentages and no homeostatic disruption as evidenced by the absence of programmed death-1 and Ly-49 surface receptors. Mixed bone marrow chimeras showed that the inability iNKT cells to make IL-4 is cell extrinsic and can be rescued in the presence of wild type APCs. Collectively, these data demonstrate that, although MΦ LRP may not be necessary for IFN-γ responses, it can contribute to iNKT cell activation by enhancing early IL-4 secretion.

Indexed as

Adaptive ImmunityAnimalsAntigens, CD1dB-LymphocytesCells, CulturedCytokinesDendritic CellsGene Knockout TechniquesImmunoglobulin ELow Density Lipoprotein Receptor-Related Protein-1Lymphocyte ActivationMacrophagesMice, Inbred C57BLMice, KnockoutNatural Killer T-CellsReceptors, LDLAntigens, CD1dCD1d antigen, mouseCytokinesImmunoglobulin ELow Density Lipoprotein Receptor-Related Protein-1Lrp1 protein, mouseReceptors, LDLTumor Suppressor Proteins

Identifiers

PMID25050824
PMCPMC4106787
OpenAlexW2059308131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.